Considering that the PI3K/AKT signaling pathway is a fundamental and extensively expressed mechanism in various cell types, imprecise delivery of PI3K/AKT modulators can trigger systemic reactions, such as metabolic disorders, immunosuppression, and skin toxicity, thus narrowing their clinical application scope. The gene discussed is PIK3CA; the disease is metabolic disease.